Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Churchill Capital Corp XI - Class A Ordinary Shares
(NQ:
CCXI
)
9.290
UNCHANGED
Delayed Quote
Updated: 4:00 PM EST, Nov 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Churchill Capital Corp XI - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
The First U.S. Humanoid Robot Stock Starts Trading in November. Here's Why I'd Wait for the De-SPAC Dip.
↗
November 01, 2026
Like so many other stocks of new cutting-edge companies, the hype surrounding this one is already uncomfortably thick.
Via
The Motley Fool
Topics
Initial Public Offering
Agility Robotics and Churchill Capital Corp XI Announce Expected Gross Capital Raise of Approximately $465 Million and Anticipated Closing of Business Combination
October 30, 2026
From
Agility Robotics, Inc
Via
GlobeNewswire
GXO Logistics Is Turning Warehouse Robots Into a Growth Strategy
↗
October 27, 2026
GXO Logistics is deploying Agility Robotics' humanoid robots via a RaaS model to cut labor costs, as rising short interest and institutional buying set up volatility ahead of Nov. 4 earnings.
Via
MarketBeat
Topics
Economy
Agility Robotics Highlights Commercial Momentum and Growing Enterprise Demand for Digit Humanoid Robot
October 26, 2026
From
Agility Robotics, Inc
Via
GlobeNewswire
Agility Robotics Expands NVIDIA Collaboration as It Prepares Digit 5 for Commercial Scale
October 22, 2026
Digit 5 Will Consolidate Onboard Compute to NVIDIA IGX Thor Modules, Building on Companies’ Humanoid Safety Collaboration
From
Agility Robotics, Inc
Via
GlobeNewswire
Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments
October 21, 2026
From
Agility Robotics, Inc
Via
GlobeNewswire
AGCO and Agility Robotics Advance Smart Manufacturing with Humanoid Robot Pilot in Hesston, Kansas, Facility
October 20, 2026
AGCO to Explore Digit Robot Use in Manufacturing Operation for Repetitive, Hazardous Tasks
From
Agility Robotics, Inc
Via
GlobeNewswire
Agility Robotics Announces Audit Committee Chair for Planned Public-Company Board
October 19, 2026
Global Logistics, Finance and Investment Leader to Support Agility’s Commercial Expansion and Public-Company Governance
From
Agility Robotics, Inc
Via
GlobeNewswire
Agility Robotics and Churchill Capital Corp XI S-4 Registration Statement Declared Effective by SEC in Connection with Proposed Business Combination
October 13, 2026
From
Agility Robotics, Inc.
Via
Business Wire
The First Pure-Play Humanoid Robot Stock Is About to Go Public. Here's What Investors Need to Know About Agility Robotics.
↗
October 13, 2026
Like many other up-and-coming companies that are going public specifically because their business and their industry are clearly at a turning point, there's plenty of price-inflating hope here.
Via
The Motley Fool
Topics
Artificial Intelligence
Electric Vehicles
Agility Robotics to Livestream Analyst & Investor Day Today
October 06, 2026
From
Agility Robotics
Via
Business Wire
Agility Robotics Announces New Directors for Planned Public-Company Board
September 29, 2026
From
Agility Robotics
Via
Business Wire
Agility to Host Analyst & Investor Day on October 6, 2026
September 17, 2026
From
Agility Robotics
Via
Business Wire
Agility Robotics to Attend Upcoming Investor Conferences
August 27, 2026
From
Agility Robotics
Via
Business Wire
Agility Robotics and Churchill Capital Corp XI Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
July 14, 2026
From
Agility Robotics, Inc.
Via
Business Wire
Grounded: SpaceX Stumbles as Grok Fails to Ignite
↗
July 09, 2026
SpaceX shares fell 8% after Nasdaq 100 inclusion as Grok's market share slipped, while Tesla dropped 7% despite a delivery beat, reflecting fading AI-driven valuation premiums.
Via
MarketBeat
Topics
Artificial Intelligence
Unusual volume stocks are being observed in Monday's session.
↗
July 06, 2026
Via
Chartmill
Unusual volume stocks in Thursday's session
↗
July 02, 2026
Via
Chartmill
Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI
↗
July 02, 2026
The CCXI-Agility Robotics SPAC merger will create the first U.S.-listed pure-play humanoid equity, valued at $2.5B, with clients including Amazon and a NVIDIA partnership.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
On Wednesday, there are stocks with unusual volume. Let's take a look.
↗
July 01, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
June 30, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
June 29, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
June 26, 2026
Via
Chartmill
These stocks have an unusual volume in today's session
↗
June 25, 2026
Via
Chartmill
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
June 24, 2026
From
Agility Robotics, Inc.
Via
Business Wire
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
↗
December 12, 2022
Via
Benzinga
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
↗
November 23, 2022
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years.
Via
Benzinga
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
October 17, 2022
From
ChemoCentryx, Inc.
Via
GlobeNewswire
Biotech Stocks Well-Positioned For The Fourth Quarter
↗
October 12, 2022
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Via
Talk Markets
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From
ChemoCentryx, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.